From the Journals

Cirrhosis linked to increased risk of stroke


 

FROM JAMA NEUROLOGY

Cirrhosis of any kind was associated with an increased risk of stroke, especially hemorrhagic stroke, in a large nationally representative cohort study reported online June 5 in JAMA Neurology.

They examined a possible association in a retrospective study involving 1,618,059 Medicare beneficiaries hospitalized during a 6-year period. This included 15,586 patients (1%) who had cirrhosis at baseline. A total of 77,268 developed stroke during a mean of 4.3 years of follow-up. The overall incidence of stroke was 2.17% per year among patients with cirrhosis, compared with only 1.11% per year among those without cirrhosis.

After the data were adjusted to account for stroke risk factors, relevant comorbidities, and demographic traits, the annual incidence of any type of stroke was significantly higher with cirrhosis than without cirrhosis (hazard ratio, 1.4). The association was stronger for intracranial hemorrhage (HR, 1.9) and subarachnoid hemorrhage (HR, 2.4) than for ischemic stroke (HR, 1.3).

The results of several secondary and sensitivity analyses were consistent with those of the primary analysis, regardless of whether the cirrhosis was alcohol-related or the stroke was fatal. The association was strongest among patients who had decompensated cirrhosis and was not evident at all among patients who had mild liver disease, Dr. Parikh and his associates said (JAMA Neurol. 2017 Jun 5 [doi: 10.1001/jamaneurol.2017.0923).

This study was not designed to explore the reasons for an association between cirrhosis and stroke, but the investigators noted many possible explanations. First, “cirrhosis is accompanied by a mixed coagulopathy, with potential implications for hemorrhagic and thrombotic processes.” It has been linked to many bleeding complications, including, most recently, cerebral microhemorrhages detectable on brain MRI. In addition, the underlying causes of cirrhosis, including alcohol abuse, hepatitis infection, and metabolic disease, may also contribute to stroke risk.

Alternatively, clinicians caring for patients with cirrhosis “may limit the aggressiveness of stroke prevention” – for example, by limiting antithrombotic medications or statins – because they are mindful of the patient’s increased risk of bleeding and hepatic toxicity, the investigators said.

Recommended Reading

Get With the Guidelines propels stroke thrombolytic therapy
MDedge Internal Medicine
SPECT reveals perfusion problems in antiphospholipid syndrome
MDedge Internal Medicine
Hard road disproving that statins make you dumb
MDedge Internal Medicine
Gliflozins’ heart failure protection in type 2 diabetes confirmed
MDedge Internal Medicine
New-onset AF boosts bad HFrEF outcomes
MDedge Internal Medicine
Stroke hospitals owe all patients rapid thrombolysis
MDedge Internal Medicine
High early stroke risk for adult congenital heart disease
MDedge Internal Medicine
Prenotification, unequivocal stroke promote ultra-fast door-to-needle time
MDedge Internal Medicine
VIDEO: Stroke risk in women deserves greater attention
MDedge Internal Medicine
Benefit of rtPA in acute ischemic stroke doesn’t diminish with weight over 100 kg
MDedge Internal Medicine